Skip to main content

Headlines

Sanofi: Frexalimab Phase 2 Trial Meets Primary Goal In Relapsing Multiple Sclerosis
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Pfizer Says Pivotal Phase 3 BASIS Clinical Trial Of Marstacimab Met Primary Endpoints
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
AstraZeneca Reports Positive Results From DUO-E Phase III Trial - Quick Facts
posted:
by: Nasdaq FB FaceBook
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #FB, #FaceBook, #MetaPlatforms, #META
Icosavax Reports Positive Results From Phase 1 Trial Of IVX-A12 Against RSV & HMPV In Older Adults
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Sanofi:Dupixent Phase 3 COPD Results Presented At ATS & Published In New England Journal Of Medicine
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
FibroGen Announces Positive Data From Phase 3 Study Of Roxadustat For Treatment Of Anemia
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
AstraZeneca Reports Positive Trial Results Of Tagrisso Plus Chemotherapy In FLAURA2 Phase III Trial
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
LinkedIn to cut 716 jobs, phase out China local jobs app
posted:
by: Nasdaq MSFT MicroSoft
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #MSFT, #MicroSoft
LinkedIn to cut 716 jobs, phase out China local jobs app
posted:
by: Nasdaq MSFT MicroSoft
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #MSFT, #MicroSoft
Ascletis Pharma: China Approves To Conduct Phase IIa Clinical Trial For ASC10 To Treat RSV Infection
posted:
by: Nasdaq FB FaceBook
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #FB, #FaceBook, #MetaPlatforms, #META
Eli Lilly: Donanemab Meets Primary Endpoint In Phase 3 Study Of Early Alzheimer's Disease
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
IDEAYA Reports Positive Interim Phase 2 Data For Darovasertib, Crizotinib Combination
posted:
by: Nasdaq FB FaceBook
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #FB, #FaceBook, #MetaPlatforms, #META
Inovio Presents Data From Phase 1b Trial With INO-4201 As Ebola Booster For RVSV-ZEBOV
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
AZN : IMFINZI-based Treatment Reduces Risk Of Disease Recurrence In Lung Cancer In Phase III Trial
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Will the Fallout From the SVB Failure Change the Stock Market Phase?
posted:
by: Nasdaq FB FaceBook
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #FB, #FaceBook, #MetaPlatforms, #META